Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

SIOUX FALLS, SD – November 04, 2025 – PRESSADVANTAGE – Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred.

AND JESS, YOU SAY THIS COULD BE A GAME CHANGER. YOU KNOW, IT REALLY CAN. ABOUT 3 MILLION AMERICANS HAVE GLAUCOMA AND THIS NEW TREATMENT IS BASICALLY AN IMPLANTABLE DRUG FOR THE EYE. AND DOCTORS SAY IT ...

Synthetic cannabinoids and nicotinamide were among alternative treatment approaches discussed by Professor Augusto ...

The findings could enable earlier detection and treatment for people affected by the serious eye condition. A research team at the University of Missouri has made a discovery that could pave the way ...

Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapiesSAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today ...

Please provide your email address to receive an email when new articles are posted on . More than half of all patients treated with glaucoma medications have ocular surface disease, which ...

Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.

Glaucoma creeps in without pain or obvious symptoms, slowly damaging your optic nerve. Regular eye exams and early detection ...

Glaucoma causes vision loss by damaging the optic nerve. This leads to loss of peripheral vision and eventually blindness. The damage to the optic nerve is multifactorial, but increased ocular ...